As shown in Figure 2A, SSO pre-treatment reduced the production of inflammatory cytokines IL-6 and TNF-α on day 3 post-infection, with the lowest levels observed in the group that received intranasal SSO 6 h prior to infection. This evidence concerns the gene TNF and infection.